Pharmafile Logo
Pharmafocus logo
Advanced Search
celgene_1_02

NICE rejects Celegene’s Revlimid as second-line treatment

November 16, 2016
Research and Development, Sales and Marketing Celegene, Revlimid

NICE has decided Celegene’s multiple myeloma growth engine Revlimid (lenalidomide) will not be offered to patients as a second line …

News
nordic-nanovector-big

New CMO and Executive Management Team member for Nordic Nanovector

November 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector has recruited a new chief medical officer (CMO) and Executive Management Team member with the appointment of Dr …

Appointment

Novartis reportedly in talks to acquire Amneal in $8 billion deal

November 15, 2016
Manufacturing and Production, Sales and Marketing Amneal pharmaceuticals, Novartis, joe jimenez

Novartis are said to be eyeing a deal for Amneal pharmaceuticals in order to bolster its Sandoz generics business. Bloomsberg …

News
celgene_1_02

Celgene’s Otezla hits primary endpoint in psoriatic arthritis study

November 15, 2016
Manufacturing and Production, Research and Development Celgene, otezla, psoriatic arthritis

Celgene has unveiled new data on its selective inhibitor of phosphodiesterase 4 (PDE4) Otezla (apremilast) which shows that the treatment …

News
abbvie_0

AbbVie investigational hep C drug boasts 97.5% response rate

November 15, 2016
Manufacturing and Production, Medical Communications, Research and Development AbbVie, hepatitis C, pan-genotypic

AbbVie released details on their latest trials for their investigational, pan-genotypic regimen of glecaprevir (ABT-493)/pibrentasvir (ABT-530). In an eight week …

News

Novartis reveals positive three-year efficacy data for psoriatic arthritis drug

November 15, 2016
Manufacturing and Production, Research and Development Cosentyx, Novartis, psoriatic arthritis

Novartis has claimed that its Cosentyx (secukinumab) treatment is now the first approved fully human interleukin-17A (IL-17A) inhibitor to demonstrate …

News
teva_copy

Teva’s white elephant plant in Mexico inoperative

November 14, 2016
Manufacturing and Production Mexico, Rimsa, Teva

The Teva-Rimsa debacle continues to rumble on, with Teva’s plant in Mexico not producing any drugs for market. The plant …

News
adriane_brown

Allergan appoints Adriane M. Brown to board of directors

November 14, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan

Allergan announced that Adriana M. Brown will join its board of directors on February 2017. Adriana Brown is currently the …

Appointment

Free Pharmacovigilance Webinar: Available to view now!

November 14, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, pharmacovigilance, primevigilance

Pharmafocus, alongside PrimeVigilance, hosted a webinar on 10 November and is now available to view for free.Throughout the webinar, PrimeVigilance …

News
germany-flag-flying-german-breeze-flag-pole-waving-1398668

Roche, Bayer and more speak out against German pricing cap plans

November 14, 2016
Sales and Marketing Bayer, Germany, Roche

A number of major drug manufacturers have spoken out against German government plans to cap prescription drug pricing in the …

News
richard_cm_jones

Mereo BioPharma appoint Richard Jones as CFO

November 14, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mereo BioPharma

Mereo BioPharma, a UK-based biopharmaceutical company, has announced that Richard CM Jones has been appointed chief financial officer of the …

Appointment

Experimental Novartis leukaemia and mastocytosis drug gets FDA Priority Review

November 14, 2016
Research and Development, Sales and Marketing FDA, Novartis, acute myeloid leukaemia

The US FDA has granted Priority Review status to Novartis’ experimental drug PKC412 (midostaurin) as a treatment for advanced systemic …

News

Pfizer’s Celebrex found to be safe on hearts after 10-year clinical study

November 14, 2016
Medical Communications, Sales and Marketing Pfizer, celebrex, ibuprofen, naproxen

Pfizer’s drug, Celebrex, has been vindicated as of equivalent safety, or better, than ibuprofen and naproxen, after a 10-year study. …

News
gsk_wall

GSK emerges top of the pile for improving access to medicine

November 14, 2016
Medical Communications, Sales and Marketing Access to Medicine Index, GSK, market access, pricing

GlaxoSmithKline, the British drugmaker, has topped the overall ranking of the Access to Medicine Index, which ranks 20 top pharmaceutical …

News
top_ten_1

Top Ten articles in the Pharma Industry this week

November 11, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing November, news, pharmaceutical, top 10, top ten, top ten stories

This week has seen pharmaceutical companies defending their patent protections and host of new collaboration spring up between companies. Read …

News
almac_building

Almac Group announces £27 million global expansion

November 11, 2016
Medical Communications, Sales and Marketing Almac Group, investment

Almac Group, a global contract pharmaceutical development and manufacturing organisation, has announced that it will spend £27 million in a …

News
bionical

Bionical adds Emas Pharma in strategic acquisition

November 11, 2016
Medical Communications, Sales and Marketing Bionical, Emas pharma, acquistion

Bionical, an integrated outsourced specialist to the pharmaceutical, biotechnology and public health industry, has announced the acquisition of Emas Pharma. …

News
alexion_solirispackaging

Alexion begins internal probe into sales practices

November 11, 2016
Medical Communications Alexion, sales practices

Alexion Pharmaceuticals released a statement that it was to begin conducting an internal investigation into sales practices for Soliris (eculizumb) …

News
california

Proposition 61 defeated to allay changes on drug pricing

November 11, 2016
Medical Communications Bernie Sanders, Drug pricing, Proposition 61, california

Another major piece of voting news emerged on 9 November, with Proposition 61 voted down by Californian residents, with the …

News
ex-roche_guy

Former Roche CEO joins Arix Bioscience as senior independent director

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Arix Bioscience, a Britain-based healthcare and life science company, appointed Franz Humer as a senior independent director on 31 October. …

Appointment
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026